Skip to main navigation Skip to search Skip to main content

Comprehensive analysis of unique cases with extraordinary control over HIV replication

  • Daniel Mendoza
  • , Sarah A. Johnson
  • , Bennett A. Peterson
  • , Ven Natarajan
  • , Maria Salgado
  • , Robin L. Dewar
  • , Peter D. Burbelo
  • , Nicole A. Doria-Rose
  • , Erin H. Graf
  • , Jamieson H. Greenwald
  • , Jessica N. Hodge
  • , William L. Thompson
  • , Nancy A. Cogliano
  • , Cheryl L. Chairez
  • , Catherine A. Rehm
  • , Sara Jones
  • , Claire W. Hallahan
  • , Joseph A. Kovacs
  • , Irini Sereti
  • , Omar Sued
  • Sheila A. Peel, Robert J. O'Connell, Una O'Doherty, Tae Wook Chun, Mark Connors, Stephen A. Migueles*
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Abstract

True long-term nonprogressors (LTNPs)/elite controllers (ECs) maintain durable control over HIV replication without antiretroviral therapy. Herein we describe 4 unique persons who were distinct from conventional LTNPs/ECs in that they had extraordinarily low HIV burdens and comparatively weak immune responses. As a group, typical LTNPs/ECs have unequivocally reactive HIV-1 Western blots, viral loads below the lower threshold of clinical assays, low levels of persistent viral reservoirs, an over-representation of protective HLA alleles, and robust HIV-specific CD8+ T-cell responses. The 4 unique cases were distinguished from typical LTNPs/ECs based on weakly reactive Western blots, undetectable plasma viremia by a single copy assay, extremely low to undetectable HIV DNA levels, and difficult to isolate replication-competent virus. All 4 had at least one protective HLA allele and CD8+ T-cell responses that were disproportionately high for the low antigen levels but comparatively lower than those of typical LTNPs/ECs. These unique persons exhibit extraordinary suppression over HIV replication, therefore, higher-level control than has been demonstrated in previous studies of LTNPs/ECs. Additional insight into the full spectrum of immune-mediated suppression over HIV replication may enhance our understanding of the associated mechanisms, which should inform the design of efficacious HIV vaccines and immunotherapies.

Original languageEnglish
Pages (from-to)4645-4655
Number of pages11
JournalBlood
Volume119
Issue number20
DOIs
StatePublished - 17 May 2012

Fingerprint

Dive into the research topics of 'Comprehensive analysis of unique cases with extraordinary control over HIV replication'. Together they form a unique fingerprint.

Cite this